Suppr超能文献

上腔静脉和无名静脉梗阻的支架扩张术可允许经静脉植入起搏导线。

Stent dilation of superior vena cava and innominate vein obstructions permits transvenous pacing lead implantation.

作者信息

Ing F F, Mullins C E, Grifka R G, Nihill M R, Fenrich A L, Collins E L, Friedman R A

机构信息

Department of Pediatric Cardiology, Baylor College of Medicine, Texas Children's Hospital, Houston, USA.

出版信息

Pacing Clin Electrophysiol. 1998 Aug;21(8):1517-30. doi: 10.1111/j.1540-8159.1998.tb00238.x.

Abstract

The purpose of this study was to assess the feasibility of stent dilation of venous obstructions/occlusions to permit transvenous pacing lead implantation. Innominate vein or superior vena cava (SVG) obstruction may preclude the implantation of transvenous pacing leads. Patients with d-transposition of the great arteries, after a Mustard or Senning procedure, and children with previously placed transvenous pacing leads are at higher risk for this vascular complication. From May 1993 to January 1996, eight pediatric patients who underwent transvenous pacing lead implantation or replacement were found to have significant innominate vein or SVC obstruction or occlusion. Utilizing intravascular stents, a combined interventional and electrophysiological approach was used to relieve the venous obstruction and to permit implantation of a new transvenous pacing lead. Two patients had complete SVC occlusion requiring puncture through the obstruction with a transseptal needle. Vessel recanalization was achieved with balloon dilation and stent implantation. The remaining six patients had severe venous obstruction with a mean minimum diameter of 3.1 +/- 3.3 mm. The mean pressure gradient across the obstructed veins was 8.6 +/- 7.3 mmHg. Following implantation of 15 Palmaz P308 stents in eight vessels, the mean diameter increased to 14.2 +/- 1.9 mm and the mean pressure gradient across the stented vessels decreased to 1.0 +/- 2.0 mmHg. A transvenous pacing lead was implanted successfully through the stent(s) immediately or 6-8 weeks later. Innominate vein and SVC obstruction can be safely and effectively relieved with intravascular stents and permit immediate or subsequent transvenous pacing lead implantation.

摘要

本研究的目的是评估对静脉阻塞/闭塞进行支架扩张以允许经静脉植入起搏导线的可行性。无名静脉或上腔静脉(SVG)阻塞可能会妨碍经静脉起搏导线的植入。大动脉d型转位患者在接受Mustard或Senning手术后,以及先前已植入经静脉起搏导线的儿童发生这种血管并发症的风险较高。1993年5月至1996年1月,8例接受经静脉起搏导线植入或更换的儿科患者被发现存在明显的无名静脉或上腔静脉阻塞或闭塞。利用血管内支架,采用介入和电生理相结合的方法来缓解静脉阻塞,并允许植入新的经静脉起搏导线。2例患者存在上腔静脉完全闭塞,需要用穿间隔针穿刺穿过阻塞部位。通过球囊扩张和支架植入实现了血管再通。其余6例患者存在严重静脉阻塞,平均最小直径为3.1±3.3mm。阻塞静脉两端的平均压力阶差为8.6±7.3mmHg。在8条血管中植入15枚Palmaz P308支架后,平均直径增加到14.2±1.9mm,支架植入血管两端的平均压力阶差降至1.0±2.0mmHg。立即或在6 - 8周后成功地通过支架植入了经静脉起搏导线。无名静脉和上腔静脉阻塞可以通过血管内支架安全有效地缓解,并允许立即或随后植入经静脉起搏导线。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验